Loading...

We've got a brand new version of Simply Wall St! Try it out

Johnson Chemical Pharmaceutical Works

GTSM:4747
Snowflake Description

Flawless balance sheet average dividend payer.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
4747
GTSM
NT$1B
Market Cap
  1. Home
  2. TW
  3. Pharmaceuticals & Biotech
Company description

Johnson Chemical Pharmaceutical Works Co., Ltd. The last earnings update was 7 days ago. More info.


Add to Portfolio Compare Print
4747 Share Price and Events
7 Day Returns
-0.4%
GTSM:4747
-1.7%
TW Pharmaceuticals
-0.5%
TW Market
1 Year Returns
0.4%
GTSM:4747
16%
TW Pharmaceuticals
17.7%
TW Market
4747 Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Johnson Chemical Pharmaceutical Works (4747) -0.4% -0.9% -1.9% 0.4% 4.1% -38.3%
TW Pharmaceuticals -1.7% 3.4% 3.5% 16% -10.7% -23.2%
TW Market -0.5% 2.8% 9.1% 17.7% 26.3% 26.1%
1 Year Return vs Industry and Market
  • 4747 underperformed the Pharmaceuticals industry which returned 16% over the past year.
  • 4747 underperformed the Market in Taiwan, Province of China which returned 17.7% over the past year.
Price Volatility
4747
Industry
5yr Volatility vs Market
Related Companies

Sorry, no analysis for Johnson Chemical Pharmaceutical Works's competitors could be found in our database.

Value

 Is Johnson Chemical Pharmaceutical Works undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Johnson Chemical Pharmaceutical Works to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Johnson Chemical Pharmaceutical Works.

GTSM:4747 Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model Dividend Discount Model
Dividend Per Share Company Filings (2019-09-30) in TWD NT$ 1.650000
Payout Ratio Company Filings (2019-09-30) 9193.1%
Discount Rate (Cost of Equity) See below 7.5%
Perpetual Growth Rate 10-Year TW Government Bond Rate 2.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for GTSM:4747
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year TW Govt Bond Rate 2.7%
Equity Risk Premium S&P Global 6%
Pharmaceuticals Unlevered Beta Simply Wall St/ S&P Global 0.69
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.687 (1 + (1- 20%) (0%))
0.794
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.8
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (0.8 * 5.96%)
7.5%

Discounted Cash Flow Calculation for GTSM:4747 using Dividend Discount Model Model

The calculations below outline how an intrinsic value for Johnson Chemical Pharmaceutical Works is arrived at by discounting future dividends to their present value. This approach is used for finance firms where free cash flow is difficult to estimate (e.g. Banks/ Insurance firms).

If the firm does not pay the majority of its earnings out as a dividend this method will often arrive at a value significantly lower than the share price.

See our documentation to learn about this calculation.

GTSM:4747 Gordon Growth Model
Calculation Result
Value per share = Expected dividends per share / (Discount Rate - Perpetual growth rate)
= NT$1.65 / (7.5% - 2.73%)
NT$23.85
GTSM:4747 Discount to Share Price
Calculation Result
Value per share (TWD) From above. NT$23.85
Current discount Discount to share price of NT$38.40
= -1 x (NT$38.40 - NT$23.85) / NT$23.85
-61%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of Johnson Chemical Pharmaceutical Works is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Johnson Chemical Pharmaceutical Works's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Johnson Chemical Pharmaceutical Works's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
GTSM:4747 PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-09-30) in TWD NT$2.03
GTSM:4747 Share Price ** GTSM (2019-11-18) in TWD NT$38.4
Taiwan, Province of China Pharmaceuticals Industry PE Ratio Median Figure of 26 Publicly-Listed Pharmaceuticals Companies 22.23x
Taiwan, Province of China Market PE Ratio Median Figure of 1,423 Publicly-Listed Companies 16.59x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Johnson Chemical Pharmaceutical Works.

GTSM:4747 PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= GTSM:4747 Share Price ÷ EPS (both in TWD)

= 38.4 ÷ 2.03

18.93x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Johnson Chemical Pharmaceutical Works is good value based on earnings compared to the TW Pharmaceuticals industry average.
  • Johnson Chemical Pharmaceutical Works is overvalued based on earnings compared to the Taiwan, Province of China market.
Price based on expected Growth
Does Johnson Chemical Pharmaceutical Works's expected growth come at a high price?
Raw Data
GTSM:4747 PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 18.93x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
1.4%per year
Taiwan, Province of China Pharmaceuticals Industry PEG Ratio Median Figure of 5 Publicly-Listed Pharmaceuticals Companies 0.89x
Taiwan, Province of China Market PEG Ratio Median Figure of 247 Publicly-Listed Companies 1.07x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Johnson Chemical Pharmaceutical Works, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Johnson Chemical Pharmaceutical Works's assets?
Raw Data
GTSM:4747 PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-09-30) in TWD NT$27.38
GTSM:4747 Share Price * GTSM (2019-11-18) in TWD NT$38.4
Taiwan, Province of China Pharmaceuticals Industry PB Ratio Median Figure of 45 Publicly-Listed Pharmaceuticals Companies 2.17x
Taiwan, Province of China Market PB Ratio Median Figure of 1,936 Publicly-Listed Companies 1.44x
GTSM:4747 PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= GTSM:4747 Share Price ÷ Book Value per Share (both in TWD)

= 38.4 ÷ 27.38

1.4x

* Primary Listing of Johnson Chemical Pharmaceutical Works.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Johnson Chemical Pharmaceutical Works is good value based on assets compared to the TW Pharmaceuticals industry average.
X
Value checks
We assess Johnson Chemical Pharmaceutical Works's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Pharmaceuticals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Pharmaceuticals industry average (and greater than 0)? (1 check)
  5. Johnson Chemical Pharmaceutical Works has a total score of 2/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Johnson Chemical Pharmaceutical Works expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

  • No analysts cover Johnson Chemical Pharmaceutical Works, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
1.4%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Johnson Chemical Pharmaceutical Works expected to grow at an attractive rate?
  • Johnson Chemical Pharmaceutical Works's earnings growth is positive but not above the low risk savings rate of 2.7%.
Growth vs Market Checks
  • Johnson Chemical Pharmaceutical Works's earnings growth is positive but not above the Taiwan, Province of China market average.
  • Unable to compare Johnson Chemical Pharmaceutical Works's revenue growth to the Taiwan, Province of China market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
GTSM:4747 Future Growth Rates Data Sources
Data Point Source Value (per year)
GTSM:4747 Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts 1.4%
Taiwan, Province of China Pharmaceuticals Industry Earnings Growth Rate Market Cap Weighted Average 11.8%
Taiwan, Province of China Pharmaceuticals Industry Revenue Growth Rate Market Cap Weighted Average 20.2%
Taiwan, Province of China Market Earnings Growth Rate Market Cap Weighted Average 11.4%
Taiwan, Province of China Market Revenue Growth Rate Market Cap Weighted Average 8%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
GTSM:4747 Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in TWD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
GTSM:4747 Past Financials Data
Date (Data in TWD Millions) Revenue Cash Flow Net Income *
2019-09-30 411 47 61
2019-06-30 410 53 59
2019-03-31 412 72 59
2018-12-31 412 68 57
2018-09-30 405 83 54
2018-06-30 407 65 58
2018-03-31 402 55 58
2017-12-31 395 40 60
2017-09-30 396 36 62
2017-06-30 381 41 58
2017-03-31 382 54 60
2016-12-31 392 68 63

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Johnson Chemical Pharmaceutical Works's earnings are expected to grow by 1.4% yearly, however this is not considered high growth (20% yearly).
  • Unable to determine if Johnson Chemical Pharmaceutical Works is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
GTSM:4747 Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Johnson Chemical Pharmaceutical Works Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

GTSM:4747 Past Financials Data
Date (Data in TWD Millions) EPS *
2019-09-30 2.03
2019-06-30 1.97
2019-03-31 1.96
2018-12-31 1.91
2018-09-30 1.80
2018-06-30 1.92
2018-03-31 1.92
2017-12-31 2.00
2017-09-30 2.05
2017-06-30 1.94
2017-03-31 2.00
2016-12-31 2.11

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Johnson Chemical Pharmaceutical Works will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Johnson Chemical Pharmaceutical Works's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Taiwan, Province of China market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Taiwan, Province of China market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Johnson Chemical Pharmaceutical Works has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Johnson Chemical Pharmaceutical Works performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Johnson Chemical Pharmaceutical Works's growth in the last year to its industry (Pharmaceuticals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Johnson Chemical Pharmaceutical Works's year on year earnings growth rate was negative over the past 5 years and the most recent earnings are below average.
  • Johnson Chemical Pharmaceutical Works's 1-year earnings growth exceeds its 5-year average (12.7% vs -4.6%)
  • Johnson Chemical Pharmaceutical Works's earnings growth has not exceeded the TW Pharmaceuticals industry average in the past year (12.7% vs 12.7%).
Earnings and Revenue History
Johnson Chemical Pharmaceutical Works's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Johnson Chemical Pharmaceutical Works Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

GTSM:4747 Past Revenue, Cash Flow and Net Income Data
Date (Data in TWD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-09-30 410.74 60.91 102.36 10.13
2019-06-30 409.67 59.02 102.62 9.91
2019-03-31 411.78 58.78 100.53 9.49
2018-12-31 411.91 57.29 98.79 9.32
2018-09-30 404.70 54.06 95.64 8.28
2018-06-30 407.07 57.51 96.24 7.29
2018-03-31 402.24 57.67 96.10 7.07
2017-12-31 394.61 60.01 95.81 6.95
2017-09-30 395.66 61.60 96.58 7.28
2017-06-30 381.13 58.17 95.07 8.18
2017-03-31 382.46 59.90 95.12 8.41
2016-12-31 392.42 63.45 97.15 9.73
2016-09-30 391.94 67.03 96.48 11.40
2016-06-30 395.42 69.72 97.09 12.84
2016-03-31 389.93 67.47 95.56 16.73
2015-12-31 380.18 62.13 97.23 15.72
2015-09-30 365.69 54.76 97.99 14.28
2015-06-30 370.13 62.16 96.85 13.41
2015-03-31 364.66 67.52 93.77 15.72
2014-12-31 362.05 71.56 94.41 14.94
2014-09-30 362.95 83.40 87.80 14.65
2014-06-30 342.93 73.69 87.91 13.10
2014-03-31 327.82 69.32 90.16 6.32
2013-12-31 313.52 65.79 85.48 5.63
2013-09-30 293.05 55.52 84.30 3.61
2013-06-30 283.49 59.78 85.92 2.57
2013-03-31 272.88 57.55 82.76 0.80
2012-12-31 266.31 52.71 85.71

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Johnson Chemical Pharmaceutical Works has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Johnson Chemical Pharmaceutical Works used its assets more efficiently than the TW Pharmaceuticals industry average last year based on Return on Assets.
  • Johnson Chemical Pharmaceutical Works's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Johnson Chemical Pharmaceutical Works's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Pharmaceuticals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Johnson Chemical Pharmaceutical Works has a total score of 2/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Johnson Chemical Pharmaceutical Works's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Johnson Chemical Pharmaceutical Works's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Johnson Chemical Pharmaceutical Works is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Johnson Chemical Pharmaceutical Works's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Johnson Chemical Pharmaceutical Works's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Johnson Chemical Pharmaceutical Works has no debt, it does not need to be covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Johnson Chemical Pharmaceutical Works Company Filings, last reported 1 month ago.

GTSM:4747 Past Debt and Equity Data
Date (Data in TWD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-09-30 829.00 0.00 284.86
2019-06-30 816.60 0.00 330.75
2019-03-31 853.26 0.00 327.03
2018-12-31 836.53 0.00 309.81
2018-09-30 822.25 0.00 312.14
2018-06-30 819.30 0.00 355.92
2018-03-31 863.98 0.00 327.21
2017-12-31 835.43 0.00 305.91
2017-09-30 820.63 0.00 297.06
2017-06-30 805.46 0.00 362.15
2017-03-31 848.06 0.00 339.89
2016-12-31 832.42 0.00 332.95
2016-09-30 816.16 0.00 322.90
2016-06-30 804.42 0.00 377.51
2016-03-31 840.79 0.00 349.40
2015-12-31 821.60 0.00 413.16
2015-09-30 805.87 0.00 485.22
2015-06-30 791.43 0.00 540.12
2015-03-31 842.07 0.00 530.91
2014-12-31 635.01 0.00 331.06
2014-09-30 619.58 0.00 333.41
2014-06-30 597.74 0.00 343.87
2014-03-31 601.44 0.00 324.37
2013-12-31 583.54 0.00 297.38
2013-09-30 397.77 0.00 133.79
2013-06-30 385.64 0.00 148.36
2013-03-31 391.45 0.00 139.54
2012-12-31 377.08 0.00 109.38
  • Johnson Chemical Pharmaceutical Works has no debt.
  • Johnson Chemical Pharmaceutical Works has not taken on any debt in the past 5 years.
  • Johnson Chemical Pharmaceutical Works has no debt, it does not need to be covered by operating cash flow.
  • Johnson Chemical Pharmaceutical Works has no debt, therefore coverage of interest payments is not a concern.
X
Financial health checks
We assess Johnson Chemical Pharmaceutical Works's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Johnson Chemical Pharmaceutical Works has a total score of 6/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Johnson Chemical Pharmaceutical Works's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
4.3%
Current annual income from Johnson Chemical Pharmaceutical Works dividends.
If you bought NT$2,000 of Johnson Chemical Pharmaceutical Works shares you are expected to receive NT$86 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Johnson Chemical Pharmaceutical Works's pays a higher dividend yield than the bottom 25% of dividend payers in Taiwan, Province of China (2.57%).
  • Johnson Chemical Pharmaceutical Works's dividend is below the markets top 25% of dividend payers in Taiwan, Province of China (5.93%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
GTSM:4747 Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Taiwan, Province of China Pharmaceuticals Industry Average Dividend Yield Market Cap Weighted Average of 23 Stocks 2.8%
Taiwan, Province of China Market Average Dividend Yield Market Cap Weighted Average of 1323 Stocks 4.1%
Taiwan, Province of China Minimum Threshold Dividend Yield 10th Percentile 1.4%
Taiwan, Province of China Bottom 25% Dividend Yield 25th Percentile 2.6%
Taiwan, Province of China Top 25% Dividend Yield 75th Percentile 5.9%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

GTSM:4747 Past Annualized Dividends Data
Date (Data in NT$) Dividend per share (annual) Avg. Yield (%)
2019-03-28 1.650 4.151
2019-03-27 1.650 3.913
2018-03-30 1.800 4.491
2017-03-30 1.900 5.067
2016-03-30 1.750 4.561
2015-03-31 2.150 5.138
2014-05-14 0.889 1.363
2014-03-28 0.889 1.234
2013-11-15 0.909 1.200
2013-08-14 0.909 1.151
2013-07-25 0.909 1.277
2013-04-30 0.909 1.955
2010-06-14 0.426 2.210
2010-02-03 0.426 2.399

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Dividends per share have been stable in the past 10 years.
  • Dividends per share have increased over the past 10 years.
Current Payout to shareholders
What portion of Johnson Chemical Pharmaceutical Works's earnings are paid to the shareholders as a dividend.
  • Dividends paid are covered by earnings (1.2x coverage).
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Johnson Chemical Pharmaceutical Works's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.4%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Johnson Chemical Pharmaceutical Works afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Johnson Chemical Pharmaceutical Works has a total score of 4/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Johnson Chemical Pharmaceutical Works's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
P. Huang
TENURE AS CEO 20.8 years
CEO Bio

Mr. P.H Huang serves as Chairman & Chief Executive Officer at Johnson Chemical Pharmaceutical Works Co., Ltd. Mr. Huang began his career with JCP in 1972 as a sales assistant, and subsequently served in a number of leadership positions prior to his appointment as Chief Executive Officer in 1999. Mr. Huang was elected to serve as President of TPMA from 2006 to 2012, during which he advocated for the benefits of general public and the pharmaceutical manufacturing industry through his expert opinion based on for many years of policy and leadership experience in Taiwan’s healthcare industry. The mission of JCP, as envisioned by company founder Mr. Johnson Huang, is to help people live healthier lives. Building upon the core values of Johnson Huang, he has successfully transformed JCP into a PIC/S certified pharmaceutical company. He serves as Standing Supervisor at Chinese Pharmaceutical Manufacture and Development Association, Standing Director at Taiwan Generic Pharmaceutical Association, Standing Director at Taiwan Pharmaceutical Marketing & Management Association, Director at Chinese National Federation of Industries, Director at Institute for Biotechnology and Medicine Industry and Board Member at Taiwan Drug Relief Foundation.

CEO Compensation
  • Insufficient data for P. to compare compensation growth.
  • Insufficient data for P. to establish whether their remuneration is reasonable compared to companies of similar size in Taiwan, Province of China.
Management Team Tenure

Average tenure of the Johnson Chemical Pharmaceutical Works management team in years:

9.8
Average Tenure
  • The average tenure for the Johnson Chemical Pharmaceutical Works management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

P. Huang

TITLE
Chairman & CEO
TENURE
20.8 yrs

Grace Chen

TITLE
Finance Director
TENURE
5.8 yrs

Weike Lin

TITLE
Sales Director
TENURE
9.8 yrs

Guo An Liao

TITLE
Deputy General Manager and Director

Jack Chiu

TITLE
Chief Research Officer
Board of Directors

P. Huang

TITLE
Chairman & CEO

Guo An Liao

TITLE
Deputy General Manager and Director

Bo Xun Huang

TITLE
Director

Rong Fu Yang

TITLE
Director

Min Yu Guo

TITLE
Director

Jun Yan Fang

TITLE
Supervisor

Jun Xiong Huang

TITLE
Supervisor
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (NT$) Value (NT$)
X
Management checks
We assess Johnson Chemical Pharmaceutical Works's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Johnson Chemical Pharmaceutical Works has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures and sells prescription drugs in Taiwan. The company offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamin, anti-inflammatory, cough and cold, pain reliever, etc. It provides its products in the solid dosage, capsule, tablet, and powder and granule, as well as nasal spray forms. The company was founded in 1966 and is based in New Taipei City, Taiwan.

Details
Name: Johnson Chemical Pharmaceutical Works Co., Ltd.
4747
Exchange: GTSM
Founded: 1966
NT$1,152,720,000
30,018,750
Website: http://www.jcpjohnson.com.tw
Address: Johnson Chemical Pharmaceutical Works Co., Ltd.
31, San Ho Road,
Sec. 4,
New Taipei City,
241,
Taiwan
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
GTSM 4747 Common Stock Taipei Exchange TW TWD 08. Jan 2010
Number of employees
Current staff
Staff numbers
156
Johnson Chemical Pharmaceutical Works employees.
Industry
Pharmaceuticals
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/11/18 15:30
End of day share price update: 2019/11/18 00:00
Last earnings filing: 2019/11/11
Last earnings reported: 2019/09/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.